Frontiers in Medicine | Hepatobiliary Diseases

Original Research

Published on 25 Sep 2025

Experimental study and clinical significance of the impact of gastrointestinal motility disorders on hepatic blood perfusion

in Hepatobiliary Diseases

Jin Tonghui
Liu Tiejun
Liu Chaoyue
Wang Han

Frontiers in Medicine

doi 10.3389/fmed.2025.1643351

1,772 views

Original Research

Published on 24 Sep 2025

REDD1 attenuates cholestatic liver fibrosis and suppresses PI3K/AKT/mTOR pathway

in Hepatobiliary Diseases

Xiaonan Li
Xin Liu
Xinrui Shi
Zixu Li
Qizhi Shuai
Tingjuan Huang
Yun Liu
Junjie Ren

Frontiers in Medicine

doi 10.3389/fmed.2025.1628260

2,412 views

Case Report

Published on 24 Sep 2025

Case Report: A rare case of giant gallbladder associated with adverse reactions to anlotinib

in Hepatobiliary Diseases

Jihao Cheng
Xin Wang
Jingyun Liao
Yuping Shen

Frontiers in Medicine

doi 10.3389/fmed.2025.1665373

1,853 views
1 citation

Case Report

Published on 19 Sep 2025

MRI findings of pancreatic intraductal oncocytic papillary neoplasm: three case reports and review of literature

in Hepatobiliary Diseases

Yunan Xiang
Xiaojun Chen
Xiafei Zhan
Zhihan Yan
Jiangfeng Pan
Xinyu Wang

Frontiers in Medicine

doi 10.3389/fmed.2025.1650931

1,548 views

Original Research

Published on 18 Sep 2025

Development and validation of a predictive model for invasive syndrome in patients with Klebsiella pneumoniae liver abscess

in Hepatobiliary Diseases

Liyong Zhang
Jiaqi Chen
Yihao Qu
Xidong Cao
Jinhua Cui
Jian Li
Aijun Yu

Frontiers in Medicine

doi 10.3389/fmed.2025.1663407

1,858 views
3 citations

Original Research

Published on 12 Sep 2025

Mapping artificial intelligence adoption in hepatology practice and research: challenges and opportunities in MENA region

in Hepatobiliary Diseases

Mohamed El-Kassas
Rofida Khalifa
Mohammed A. Medhat
Yusuf Yilmaz
Ali Tumi
Asma Labidi
Maen Almattooq
Faisal M. Sanai
Mohamed Elbadry
Mohammed Omer Mohammed

Frontiers in Medicine

doi 10.3389/fmed.2025.1630831

4,078 views

Original Research

Published on 10 Sep 2025

A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice

in Hepatobiliary Diseases

Yi Pan
Feng Xue
Shanshan Wang
Bihui Zhong
Yutao Zhan
Qi Wang
Youqing Xu
Huiying Rao
Yuqiang Mi
Yuemin Nan

Frontiers in Medicine

doi 10.3389/fmed.2025.1610083

3,983 views

Original Research

Published on 10 Sep 2025

Global, regional, and national burden of acute hepatitis (1990–2021): a systematic analysis of the global burden of disease in 2021

in Hepatobiliary Diseases

Zhixun Bai
Yanjin Chen
Jiaxi Chen
Wenyi Pang
Rubin Zheng
Miao Deng
Rui Sun
Yongping Lan
Houze Li

Frontiers in Medicine

doi 10.3389/fmed.2025.1620371

2,507 views
1 citation

Original Research

Published on 08 Sep 2025

Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma

in Hepatobiliary Diseases

Yanxi Luo
Zhigao Hu
Guoxiu Du
Wanpeng Xin
Minglong Wang

Frontiers in Medicine

doi 10.3389/fmed.2025.1622209

1,917 views

Review

Published on 03 Sep 2025

Mechanisms of biliary stricture and novel therapeutic strategies

in Hepatobiliary Diseases

Boming Peng
Jianquan Zhang
Yang Xiang

Frontiers in Medicine

doi 10.3389/fmed.2025.1609461

3,080 views
1 citation

Case Report

Published on 02 Sep 2025

Subacute liver failure caused by hyperthyroidism and complicated by drugs: a case report and review of the literature

in Hepatobiliary Diseases

Yiwei Hou
Mingxu Tong
Yu Yang
Zijun Zhou
Yunxi Fu
Zhennian Gou
Jinting Xi
Xiangyu Liao
Shixin Li
Wufei Zhu

Frontiers in Medicine

doi 10.3389/fmed.2025.1629957

2,059 views

Original Research

Published on 02 Sep 2025

Adverse events of ursodeoxycholic acid: a real-world pharmacovigilance study using FAERS (2004–2023)

in Hepatobiliary Diseases

Yahui Ni
Xin Guan
Xiaoxue Gao
Ya Wang
Dongyuan Qin
Zhangtao Shan
Na Wang

Frontiers in Medicine

doi 10.3389/fmed.2025.1574308

5,057 views
1 citation

Original Research

Published on 01 Sep 2025

Unanticipated discovery: basal metabolic rate as an independent risk factor for metabolic dysfunction-associated steatotic liver disease in a 5-year longitudinal cohort study of non-obese individuals in China

in Hepatobiliary Diseases

Jian Luo
Danfeng Gong
Min Guo
Long Cheng
Xueyan Wu

Frontiers in Medicine

doi 10.3389/fmed.2025.1569655

2,273 views
1 citation

Original Research

Published on 29 Aug 2025

ISImatsuda as a potential predictor of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

in Hepatobiliary Diseases

Jing Liu
Yueqiu Wang
Xinghang Zhou
Zaixin Wen
Yu Chen
Yiqiong Sun
Shuaiying Su
Weiwei Lin
Ruiting Shen
Xiaoyu Sun

Frontiers in Medicine

doi 10.3389/fmed.2025.1623808

2,274 views

Correction

Published on 29 Aug 2025

Correction: Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma

in Hepatobiliary Diseases

Frontiers Production Office

Frontiers in Medicine

doi 10.3389/fmed.2025.1682417

1,271 views

Original Research

Published on 26 Aug 2025

Enhanced glycolysis is associated with aggressive tumor phenotype and worse outcomes in hepatocellular carcinoma patients

in Hepatobiliary Diseases

Masanori Oshi
Colin Rog
Li Yan
Itaru Endo
Kazuaki Takabe

Frontiers in Medicine

doi 10.3389/fmed.2025.1588604

2,049 views

Correction

Published on 22 Aug 2025

Correction: Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis

in Hepatobiliary Diseases

Xianjing Jin
Jing Xu
Xiaochun Weng

Frontiers in Medicine

doi 10.3389/fmed.2025.1683822

1,079 views

Case Report

Published on 22 Aug 2025

Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review

in Hepatobiliary Diseases

Xiaoxue Zhang
Mingyu Peng
Ruichen Ren
Wenting Li
Qingyuan Zhao
Chengcheng Qi
Yang Zhang

Frontiers in Medicine

doi 10.3389/fmed.2025.1604853

2,077 views

Original Research

Published on 20 Aug 2025

Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study

in Hepatobiliary Diseases

Lingde Shen
Yuanfang Lin
Weifeng Chen
Hui Peng

Frontiers in Medicine

doi 10.3389/fmed.2025.1565997

2,087 views
2 citations

Case Report

Published on 20 Aug 2025

Case Report: Hepatocellular adenoma due to long-term oral stanozolol administration

in Hepatobiliary Diseases

Ya-Nan Qin
Chang-Ming Tao
Tian-Tian Guo
Jing-Jing Liu
Wei-Chang Luan
Chun-Hua Liu

Frontiers in Medicine

doi 10.3389/fmed.2025.1654316

2,041 views

Original Research

Published on 19 Aug 2025

An in-depth analysis of research on posthepatectomy liver failure (2006-2024): exploring trends and future directions through a bibliometric approach

in Hepatobiliary Diseases

Yachen Wu
Jiangtao Li
Zhaohai Liu
Mengliang Jiang
Hao Liang
Sajid Ameer
Xilin Qu
Zhangtao Long
Zhu Zhu
Xiaoming Dai

Frontiers in Medicine

doi 10.3389/fmed.2025.1598579

4,839 views

Brief Research Report

Published on 18 Aug 2025

Recurrent SLCO1B1 and SLCO1B3 mutations identified in three patients with Rotor syndrome

in Hepatobiliary Diseases

Chenyu Zhao
Hui Huang

Frontiers in Medicine

doi 10.3389/fmed.2025.1630360

1,715 views

Original Research

Published on 18 Aug 2025

Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response

in Hepatobiliary Diseases

Jin-Shu Pang
Yu Yang
Li Liang
Yu-Jia Zhao
Jin-Dan Li
Li-Peng Li
Xue-Xin Wei
Rui-Zhi Gao
Rong Wen
Yun He

Frontiers in Medicine

doi 10.3389/fmed.2025.1596120

2,289 views
1 citation

Original Research

Published on 15 Aug 2025

Burden and risk factors for gallbladder and biliary tract diseases in China from 1990 to 2021 and burden predictions of risk factors for the next 15 years

in Hepatobiliary Diseases

Shijun Zhao
Yan Zhou
Wangyou Tang
Cheng Zhao
Lang Wang
Xianglin Zhu
Hao Liang
Jie Zhang
Tian Gao
Yinlu Ding

Frontiers in Medicine

doi 10.3389/fmed.2025.1528608

2,724 views

410 articles

articles

Experimental study and clinical significance of the impact of gastrointestinal motility disorders on hepatic blood perfusion

REDD1 attenuates cholestatic liver fibrosis and suppresses PI3K/AKT/mTOR pathway

Case Report: A rare case of giant gallbladder associated with adverse reactions to anlotinib

MRI findings of pancreatic intraductal oncocytic papillary neoplasm: three case reports and review of literature

Development and validation of a predictive model for invasive syndrome in patients with Klebsiella pneumoniae liver abscess

Mapping artificial intelligence adoption in hepatology practice and research: challenges and opportunities in MENA region

A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice

Global, regional, and national burden of acute hepatitis (1990–2021): a systematic analysis of the global burden of disease in 2021

Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma

Mechanisms of biliary stricture and novel therapeutic strategies

Subacute liver failure caused by hyperthyroidism and complicated by drugs: a case report and review of the literature

Adverse events of ursodeoxycholic acid: a real-world pharmacovigilance study using FAERS (2004–2023)

Unanticipated discovery: basal metabolic rate as an independent risk factor for metabolic dysfunction-associated steatotic liver disease in a 5-year longitudinal cohort study of non-obese individuals in China

ISImatsuda as a potential predictor of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

Correction: Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma

Enhanced glycolysis is associated with aggressive tumor phenotype and worse outcomes in hepatocellular carcinoma patients

Correction: Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis

Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review

Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study

Case Report: Hepatocellular adenoma due to long-term oral stanozolol administration

An in-depth analysis of research on posthepatectomy liver failure (2006-2024): exploring trends and future directions through a bibliometric approach

Recurrent SLCO1B1 and SLCO1B3 mutations identified in three patients with Rotor syndrome

Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response

Burden and risk factors for gallbladder and biliary tract diseases in China from 1990 to 2021 and burden predictions of risk factors for the next 15 years

articles

Experimental study and clinical significance of the impact of gastrointestinal motility disorders on hepatic blood perfusion

REDD1 attenuates cholestatic liver fibrosis and suppresses PI3K/AKT/mTOR pathway

Case Report: A rare case of giant gallbladder associated with adverse reactions to anlotinib

MRI findings of pancreatic intraductal oncocytic papillary neoplasm: three case reports and review of literature

Development and validation of a predictive model for invasive syndrome in patients with Klebsiella pneumoniae liver abscess

Mapping artificial intelligence adoption in hepatology practice and research: challenges and opportunities in MENA region

A real-world study of polyenyl phosphatidylcholine in the management of patients with metabolic dysfunction-associated fatty liver disease in China clinical practice

Global, regional, and national burden of acute hepatitis (1990–2021): a systematic analysis of the global burden of disease in 2021

Novel immune checkpoint inhibitor FilC/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma

Mechanisms of biliary stricture and novel therapeutic strategies

Subacute liver failure caused by hyperthyroidism and complicated by drugs: a case report and review of the literature

Adverse events of ursodeoxycholic acid: a real-world pharmacovigilance study using FAERS (2004–2023)

Unanticipated discovery: basal metabolic rate as an independent risk factor for metabolic dysfunction-associated steatotic liver disease in a 5-year longitudinal cohort study of non-obese individuals in China

ISImatsuda as a potential predictor of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus

Correction: Meta-analysis of the efficiency and safety of neoadjuvant therapy with immune checkpoint inhibitors in resectable hepatocellular carcinoma

Enhanced glycolysis is associated with aggressive tumor phenotype and worse outcomes in hepatocellular carcinoma patients

Correction: Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis

Pulmonary hypertension secondary to Abernethy malformation with left inferior vena cava: a case report and literature review

Association between lipid accumulation product and non-alcoholic fatty liver disease with normal weight: a population-based study

Case Report: Hepatocellular adenoma due to long-term oral stanozolol administration

An in-depth analysis of research on posthepatectomy liver failure (2006-2024): exploring trends and future directions through a bibliometric approach

Recurrent SLCO1B1 and SLCO1B3 mutations identified in three patients with Rotor syndrome

Elevated THOC5 expression in liver cancer and its implications for tumor progression and therapeutic response

Burden and risk factors for gallbladder and biliary tract diseases in China from 1990 to 2021 and burden predictions of risk factors for the next 15 years

Burden and risk factors for gallbladder and biliary tract diseases in China from 1990 to 2021 and burden predictions of risk factors for the next 15 years